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Undirected gene coexpression networks obtained from experimental expression data coupled with efficient computational
procedures are increasingly used to identify potentially relevant biological information (e.g., biomarkers) for a particular disease.
However, coexpression networks built from experimental expression data are in general large highly connected networks with
an elevated number of false-positive interactions (nodes and edges). In order to infer relevant information, the network must
be properly filtered and its complexity reduced. Given the complexity and the multivariate nature of the information contained
in the network, this requires the development and application of efficient feature selection algorithms to be able to exploit the
topological characteristics of the network to identify relevant nodes and edges.This paper proposes an efficientmultivariate filtering
designed to analyze the topological properties of a coexpression network in order to identify potential relevant genes for a given
disease.The algorithm has been tested on three datasets for three well known and studied diseases: acute myeloid leukemia, breast
cancer, and diffuse large B-cell lymphoma. Results have been validated resorting to bibliographic data automatically mined using
the ProteinQuest literature mining tool.
1. Introduction
Systems biology typically uses networks to model and dis-
cover emergent properties among genes, proteins, and other
relevant biomolecules referred to specific phenotypes or
diseases.
Theoretical studies have revealed that biological networks
share many features with other types of networks such as
computer or social networks. They enable the application
of several mathematical and computational methods of the
graph theory to biological studies [1, 2]. The computational
analysis of biological networks has therefore become increas-
ingly used to mine the complexity of cellular processes and
signaling pathways.
Many types of biological networks do exist, depending
on the information associated to their nodes and edges.
In general, they can be classified as directed or undirected
networks [3]. In directed networks, nodes are molecules,
while edges indicate causal biological interactions among
nodes (e.g., transcription and translation regulations [4]).
Instead, in undirected networks, an edge indicates a shared
property, such as sequence similarity [5], gene coexpression
[6–9], protein-protein interaction [10], or term cooccurrence
in the scientific literature [11–13].
Undirected gene coexpression networks, coupled with
efficient computational algorithms and complemented by
the literature mining, may represent a valuable instrument
to identify relevant information (e.g., biomarkers) for a
particular disease. However, coexpression networks built
from experimental expression data are in general large
highly connected networks with an elevated number of false-
positive interactions (nodes and edges). In order to infer
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relevant information, the network must be properly filtered
and its complexity reduced. Given the complexity and the
multivariate nature of the information contained in the
network, this requires the development and application of
efficient feature selection algorithms to be able to exploit the
network topological characteristics.
Several feature selection algorithms have been proposed
in the literature: some in the context of generic ma-
chine learning techniques [14] and others more specifically
designed to work with transcriptome data [15–21]. Following
Saeys et al. [21], feature selection methods fall in three main
categories, namely, (1)filters, (2)wrappers, and (3) embedded
methods.
Filters assess the relevance of features by looking at the
intrinsic properties of the data. They do not consider any
learning or classification model [19]. Filtering techniques
easily scale to very high-dimensional datasets. They are
computationally simple and fast, and they are independent
of any machine learning model to be applied after filtering.
However, a common disadvantage of filtering methods is
that most of the proposed techniques are univariate [19],
which is a major limitation for transcriptome data analysis.
In fact, genes tend to work according to complex gene reg-
ulatory networks, and their expression profiles are therefore
highly correlated. To overcome this limitation, multivariate
filtering techniques to some extent incorporating feature
dependencies have been introduced [22, 23]. Unfortunately,
they are in general slower and less scalable than univariate
techniques, thus preventing their application on genome-
wide transcriptome data.
Wrappers [24] and embedded approaches [17] differ from
filters since they are designed to work with specific machine
learning and classification models. The main difference
between the two groups of approaches is that in embedded
approaches feature selection is built into the classifier, while
wrappers work together with the classifier but are not part
of it. In general, these approaches are able to improve
the classification accuracy. However, different classification
models may highlight different sets of relevant genes, and
sometimes genes that might be biologically representative are
discarded by the classification model.
In this paper, we exploit gene coexpression networks
and network topological analysis to implement an efficient
multivariate filtering algorithm attempting to reduce the size
of the network under analysis and to identify sets of genes,
which have a biological relevance for a given disease. In
particular, a multiweighted coexpression network, is built
on top of collected expression data in order to efficiently
represent correlations among genes in high-dimensional
expression datasets. A topological analysis algorithm is then
applied to the coexpression network to identify regions of
the network with interesting topological properties that may
highlight relevant genes for the modeled phenomenon.
We tested the proposed approach on a set of microarray
experiments for threewell-studied diseases and compared the
obtained list of relevant genes with a bibliometric correlation
list of genes retrieved resorting to the ProteinQuest [25] tool.
Statistical analysis on the obtained results highlighted that
the proposed approach is able to strongly reduce the size of
the analyzed coexpression networks, while keeping genes that
are highly correlated with the target diseases in the scientific
literature.
2. Methods and Materials
The network filtering approach proposed in this paper in-
cludes two computational steps designed to
(1) organize the expression data into a multiweighted
coexpression network that is able to better high-
light relationships among nodes compared to single-
weighted networks, and
(2) analyze the multi-weighted network in order to iden-
tify regions of the network with interesting topolog-
ical properties that may highlight relevant genes for
the modeled phenomenon.
2.1. Multiweighted Coexpression Networks. Let us consider
a dataset of expression data (e.g., microarray data) for a
large number of DNA sequences tested under two different
conditions (e.g., healthy tissue versus diseased tissue).
We organize the dataset in the form of a gene expression
matrix GEM : 푁 × 푀 → 푒푖,푗 ∈ R with rows rep-
resenting samples and columns representing genes. Each
element of the matrix provides the differential expression
level 푒푖,푗 of gene 푔푗 (column 푗) in sample 푠푖 (row 푖) under
the two tested conditions. Among the different ways to
compute differential expression, in this paper, we exploit
the (binary) logarithm of the ratio between the absolute
expression of the gene in the two tested conditions (log
ratio). Log ratios tend to be normally distributed [26] and
enable to easily normalize expression levels from differ-
ent samples using standard score (푧 score) normalization
[27]:
푒푖,푗 = log2 (푒퐶1푖,푗/푒퐶2푖,푗) − 휇푖휎푖 , (1)
where 푒퐶1푖,푗 and 푒퐶2푖,푗 represent the absolute expression of
gene 푔푗 in sample 푠푖 under the conditions 퐶1 and 퐶2, and휇푖 and 휎푖 denote the mean and the standard deviation of log
ratios of all genes within sample 푠푖.
Normalized expression data can be used to build a single
coexpression network enabling to easily identify genes that
are coexpressed within an experiment. For our analysis we
exploit a multi-weighted coexpression network (MWNET)
that assigns multiple weights to the network edges to identify
different forms of coexpression among genes.
An MWNET is an undirected weighted graph
MWNET = (푉,퐸,푊), where
(i) vertexes 푔푗 ∈ 푉 represent genes that are differentially
expressed in at least one of the available samples;
(ii) edges 퐸 ⊆ 푉 × 푉 connect pairs of vertexes (푔푗,푔푘)
and represent genes that are coexpressed in at least a
sample;
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(iii) a weight function푊 assigns to each edge a vector of
weights:푊 : (푔푖,푔푗) ∈ 퐸 㨃㨀→ 푤⃗푖,푗 = (푤OO푖,푗 ,푤OS푖,푗 ,푤SO푖,푗 ,푤SS푖,푗) . (2)
A gene 푔푗 is considered differentially expressed in sample푠푖 if |푒푖,푗| > 휀; that is, its differential expression is greater than
a given threshold required to filter residual noise in the data.
If the differential expression of a gene is positive, it means the
gene is overexpressed in condition퐶1 compared to condition퐶2. We denote the gene as overexpressed. In the opposite
condition, that is, negative differential expression, the gene
is instead denoted as silenced.
Exploiting the concept of overexpressed and silenced
genes, each edge of the network is labeled with four weights
associated to the four combinations of expression conditions;
the pair of genes connected by the edge may assume the
following: (1) 푤OO푖,푗 both genes over-expressed, (2) 푤OS푖,푗 gene푔푖 overexpressed and 푔푗 silenced, (3) 푤SO푖,푗 gene 푔푖 silenced
and 푔푗 over-expressed, and (4) 푤SS푖,푗 both genes silenced. Each
weight counts how many times the pair of genes assumes the
selected state in the set of samples composing the dataset.
Figure 1 shortly summarizes the steps required to con-
struct an MWNET starting from raw preprocessed expres-
sion data.
Multi-weighted coexpression networks are the first orig-
inal contribution of this paper and are able to provide inter-
esting insights about gene relations. Network edges highlight
relationships among genes with the weights providing a mea-
sure of the strength and the type of the relation. Moreover,
by looking at the different edges, additional information
can be inferred. Genes connected with edges with high푤OO/푤SS score (i.e., both genes over-expressed or silenced)
may underly a biological behavior in which the two genes
enhance/silence each other, which is a common motif in
biological networks [28, 29]. Similarly genes connected with
edges with high 푤OS/푤SO may identify genes connected with
negative loops, which again is a common motif observed in
several biological networks [29–31].
2.2. Network Filtering. Multi-weighed coexpression net-
works built from experimental expression data are in general
complex highly connected networks that contain an elevated
number of false-positive interactions (edges).
The weights assigned to each edge represent a valuable
information to remove interaction with low informative
content.
Let us consider two candidate genes A and B connected
by an edge in a network built from a set of 푁 samples.
A uniform weight distribution on the edge (e.g., 푤⃗퐴,퐵 =[푁/4,푁/4,푁/4,푁/4]) identifies a low informative interac-
tion since genes show differentiated behaviors among the
different samples. Differently, if the weights are polarized
toward one of the four behaviors (e.g., 푤⃗퐴,퐵 = [푁, 0, 0, 0]),
the informative content of the edge increases.
This consideration is exploited to build a filtering mecha-
nism for the selected network. A relevance score (푅푔푖) defined
according to the following equation is assigned to each gene푔푖 of the network according to the following equation:푅푔푖 = 1푁 ∑∀푗|∃(푔푖,푔푗)∈퐸[1 − min (푤⃗푖,푗)max (푤⃗푖,푗)]⋅ [2 ⋅ 휎 (푤⃗푖,푗)푁 ] ∀푖 ∈ [1,푀] . (3)
Equation (3) tries to assign high scores to genes that are
connected to their neighbors with strong polarization. If two
genes are connectedwith almost uniformweight distribution,
the minimum and the maximum weights are similar and the
first term of the equation tends to zero thus lowering the
score. In all other cases, the more the edges are weighted with
a not uniform distribution, the more their score increases.
The relevance score introduced by (3) is used to filter
the list of nodes and edges of the network thus reducing its
complexity. Setting a threshold on the acceptable relevant
scores allows us to remove low relevant genes and their related
edges, thus obtaining a filtered list of genes and a reduced
network ready for further analyses aiming at identifying
interesting network motifs [4, 31–34].
The proposed relevance score is defined in order to high-
light those genes that manifest expression changes between
the two considered conditions 퐶1 and 퐶2 in a significant
number of samples of the considered data set. The quality
and the numerosity of the available data are therefore the
key issues to properly compute this score. This is even
more critical when samples collected for a given disease
include different phenotypes. If a given phenotype is not
properly represented in the dataset, the risk of ranking its
specific markers with low relevant scores becomes high, with
the risk of losing important biological information during
the filtering process that could provide unexpected leads
for biologic or therapeutic insights. Nevertheless, this is a
common drawback of all machine learning and statistical
methods that can only bemitigated by increasing the number
of collected samples and carefully selecting them in order to
be representative for the considered phenomenon.
Moreover, the threshold used to filter the network is a
good instrument to deal with the risk of loosing significant
genes. A tight threshold will in general filter the presence of
different phenotypes. It enables to obtain a smaller network
representative of the common properties of the considered
disease, regardless of the specific phenotypes. Instead, by
relaxing the threshold, also genes that are informative in a
reduced set of samples will be included in the filtered net-
work. Researchers may look at this low ranked genes as can-
didates nodes that are able to highlight specific phenotypes,
and therefore conduct further experimental investigations.
3. Results and Discussion
In our experimental design, we tested the proposed network
filtering algorithm on three coexpression networks obtained
from expression data for three well studied and documented
diseases with available on-line datasets.
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Figure 1: Example of construction of a MWNET. Expression data in this example are not from real experiments. They are simply used to
show the process required to construct a MWNET starting from raw expression data.
(1) Acute Myeloid Leukemia Dataset (AML): peripheral-
blood samples or bone marrow samples of interme-
diate-risk AML with a normal karyotype [35]. This
dataset includes 14 samples with 43,196 spots (45K
technology) obtained from microarray data available
at the Gene Expression Omnibus (GEO), accession
number GSE426. The complete list of selected sam-
ples is available in Table 1.
(2) Breast Cancer (BC): samples of predominantly
advanced primary breast tumor [36]. This dataset
includes 20 samples with 9,216 spots (9K technology)
obtained from microarray data available at the Gene
Expression Omnibus (GEO), accession number
GSE3281. The complete list of selected samples is
available in Table 2.
(3) Diffuse Large B-Cell Lymphoma Dataset (DLCL): a set
of samples from patients with diffuse large B-cell lym-
phoma, the most common subtype of non-Hodgkin’s
lymphoma downloaded from a larger dataset of
experiments aiming at performing Lymphoma classi-
fication [37, 38].This dataset includes 51 samples with
9,216 spots (9K technology) obtained from microar-
ray data available at the Gene Expression Omnibus
(GEO), accession number GSE60. The complete list
of selected samples is available in Table 3.
Samples have been downloaded from the cDNA Stan-
ford Microarray database [39]. All genes without a valid
Table 1: List of samples for the AML dataset. Samples are cDNA
45K array technology.
Sample number GEO accession number Experiment name
1 GSM6259 AML 13
2 GSM6266 AML 28
3 GSM6281 AML 21
4 GSM6284 AML 112
5 GSM6309 AML 32
6 GSM6317 AML 20
7 GSM6318 AML 111
8 GSM6319 AML 18
9 GSM6275 AML 1
10 GSM6285 AML 25
11 GSM6292 AML 105
12 GSM6311 AML 24
13 GSM6335 AML 16
14 GSM6337 AML 114
Unigene ID have been discarded.The normalized differential
expression for each gene has been computed according to (1)
considering the CH1I MEAN and the CH2I MEAN mean
intensity channels available for each microarray as absolute
expression level of each gene, and 휀 = 0 (1-folding). Since old
microarray technologies often used spots duplication, during
the network generation we considered as expressed those
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Table 2: List of samples for the BC data-set. Samples are cDNA 9K
array technology.
Sample
number GEO accession number Experiment name
1 GSM73756 BC-16 versus NF (svi114)
2 GSM73784 808A versus NF (svi060)
3 GSM73706 107B versus NF (svi032)
4 GSM73726 110B versus NF (svi033)
5 GSM73727 111A versus NF (svi034)
6 GSM73732 111B versus NF (svi035)
7 GSM73734 114A versus NF (svi037)
8 GSM73736 115B versus NF (svi038)
9 GSM73783 710A versus NF (svi056)
10 GSM73764 118B versus NF (svi041)
11 GSM73786 123B versus NF (svi043)
12 GSM73704 206A versus NF (svi045)
13 GSM73708 214B versus NF (svi048)
14 GSM73709 305A versus NF (svi049)
15 GSM73738 308B versus NF (svi050)
16 GSM73776 402B versus NF (svi052)
17 GSM73777 406A versus NF (svi053)
18 GSM73779 708B versus NF (svi054)
19 GSM73697 805A versus NF (svi058)
20 GSM73699 807A versus NF (svi059)
genes differentially expressed in at least one of their replica
on the microarray.
The filtering process has been executed on the three
considered datasets applying a quite relaxed threshold of 0.5
on the relevance score of (3).
Table 4 shows the aggregated results in terms of number
of genes before and after filtering, highlighting the relevant
reduction ratio. The full list of identified genes is instead
provided as Supplementary Material to this paper available
online at http://dx.doi.org/10.1155/2013/676328 (global cita-
tion summary.xlsx file—BC Filtered Genes, AML Filtered
Genes and DLCL Filtered Genes sheets).
Validation of the proposed filtering algorithm has been
performed by comparing the list of filtered genes with data
mined from the available scientific literature. It is worth
to mention here that this validation phase does not aim
at identifying new markers for the considered diseases. By
selecting three diseases that have been intensively studied
and documented, we aim at confirming how the proposed
method is able to identify relevant genes from raw expression
profiles that are widely confirmed in the available literature.
In order to rely on a large literature dataset, rather then
performing manual searches, the literature has been mined
resorting to the ProteinQuest bibliography data mining tool
[25].
ProteinQuest is an advanced text-mining tool that
exploits the web services offered by PubMed to perform
advanced semantic searches of scientific papers. It searches
for biological terms (e.g., diseases, proteins, genes, miRNAs,
Table 3: List of samples for the DLCL data-set. Samples are cDNA
9K array technology.
Sample
number GEO accession number Experiment name
1 GSM2035 DLCL-0047
2 GSM2036 DLCL-0042
3 GSM1958 DLCL-0040
4 GSM1959 DLCL-0036; OCT
5 GSM2037 DLCL-0035
6 GSM1994 DLCL-0034
7 GSM2038 DLCL-0033
8 GSM1995 DLCL-0032
9 GSM1996 DLCL-0031
10 GSM1997 DLCL-0030
11 GSM1998 DLCL-0029
12 GSM1960 DLCL-0028
13 GSM1999 DLCL-0027
14 GSM2039 DLCL-0026
15 GSM2040 DLCL-0025
16 GSM2000 DLCL-0024
17 GSM2001 DLCL-0023
18 GSM2041 DLCL-0021
19 GSM2043 DLCL-0019
20 GSM2044 DLCL-0018
21 GSM2045 DLCL-0016
22 GSM2047 DLCL-0014
23 GSM2048 DLCL-0013
24 GSM2049 DLCL-0012
25 GSM2050 DLCL-0011
26 GSM2051 DLCL-0010
27 GSM2052 DLCL-0009
28 GSM2053 DLCL-0008
29 GSM2055 DLCL-0006
30 GSM2056 DLCL-0005
31 GSM2058 DLCL-0003
32 GSM2059 DLCL-0002
33 GSM2060 DLCL-0001
34 GSM1965 DLCL-0052 ‖lc4b060
35 GSM1967 DLCL-0041 ‖lc4b061
36 GSM1968 DLCL-0039 ‖lc4b039
37 GSM1969 DLCL-0037 ‖lc4b036
38 GSM2072 DLCL-0034 ‖lc8n109
39 GSM1972 DLCL-0033 ‖lc4b034
40 GSM2073 DLCL-0032 ‖lc8n110
41 GSM2074 DLCL-0031 ‖lc8n108
42 GSM2016 DLCL-0028 ‖lc7b025
43 GSM2077 DLCL-0027 ‖lc8n095
44 GSM1974 DLCL-0025 ‖lc4b059
45 GSM2078 DLCL-0024 ‖lc8n096
46 GSM2079 DLCL-0023 ‖lc8n098
47 GSM1976 DLCL-0015 ‖lc4b063
48 GSM1977 DLCL-0011 ‖lc4b030
49 GSM1978 DLCL-0010 ‖lc4b053
50 GSM1979 DLCL-0009 ‖lc4b027
51 GSM1982 DLCL-0002 ‖lc4b033
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Table 4: Aggregated filtering results for the three considered data-
sets.
Original number
of genes
Filtered number
of genes Reduction ratio
AML 39,028 505 98.70%
BC 7,531 662 91.20%
DLCL 6,826 115 98.31%
etc.) in titles and abstracts as well as in all image captions of
all papers stored in Medline. Image captions are extracted,
from free full-text articles, using the BFO Java library
(http://bfo.com/) on the PDF version of the scientific papers
[40]. ProteinQuest is capable of inheriting the PubMedMeSH
terms indexing. ProteinQuest text-mining tool searches, in
the abstracts and figure captions of all identified publications,
for terms belonging to a manually curated protein dictionary
based on Entrez MeSH terms. Common ambiguities in the
terminology are resolved using a multiple search for more
than one alias, as well as the cooccurrence of specific words,
which can deny or force the tagging process.
ProteinQuest has been first used to manually refine the
obtained lists of filtered genes in order to remove generic
oncogenes that cannot be specifically ascribed to a selected
disease. For instance, the AML’s filtered genes contain TP53,
a tumor suppressor protein crucial inmulticellular organisms
for cell cycle regulation [41]. TP53 is a clear example of
a generic oncogene not specifically marking a particular
cancer disease. To enhance the specificity of the network
to the selected disease, it has been manually removed after
filtering.
As a preliminary validation, we searched using Protein-
Quest for all genes that have been cocited with one of the
three available diseases submitting the query: “Leukemia,
Myeloid, Acute” or “Breast Neoplasm” or “Lymphoma, Large
B-Cell, Diffuse.” The query is designed not to lose genes
included in subsets such as phenotypes, and subtypes, by
resorting to the most general keywords available for each
disease. The query selected 10,488 genes extracted from
269,641 analyzed publications, and returned for each gene
and for each disease the number of detected co-citations
(global citation summary.xlsx file—Citation Data sheet—
Columns A–D). For each disease, we sorted the list of
10,488 selected genes by their decreasing citation count,
assigning to each gene a disease gene citation ranking
(global citation summary.xlsx file—Citation Data sheet—
Columns H–J). Top ranked genes are highly cocited with
the disease. Finally, for each disease, we marked those genes
present in the list of filtered genes obtained by our filtering
algorithm. (global citation summary.xlsx file—CitationData
sheet—Columns E–G).
Starting from these citation data, Figure 2 summarizes
the preliminary validation performed for the AML dataset.
Citation data have been filtered to select the AML filtered
genes, only. Resulting data have been sorted by the AML
citation rank and the citation rank of each selected gene for
each of the three diseases has been plotted.The three citation
ranks for each gene are always vertically aligned.
Looking at the left side of Figure 2, one can notice that top
ranked genes for the AML datasets (i.e., high number of co-
citations between the gene and the disease) have, in general, a
lower rank for the other two disease (i.e., lower number of co-
citations), thus giving an indication that the genes selected by
our algorithm have a higher bibliometric correlation with the
selected disease. This selectivity decreases moving to lower
ranked genes. It is worth to remember here that filtering was
performedwith a quite relaxed threshold that on the one hand
limits the selectivity of the filtering process but, on the other
hand, preserves low ranked genes that might be important
to characterize specific phenotypes of the considered disease.
This is, for example, the case for the diffuse large B-cell
lymphoma.The considered dataset includes samples for two
well-known phenotypes of this disease: (1) GC and (2)
activated [37].Thanks to the relaxed threshold, genes CD38,
BCL7A, BCL6, MYB, PI3, CD2, CASP10 that are well known
to be differentially expressed across the two phenotypes, even
if not at the top of the ranked list, have been preserved in
the filtered network, thus enabling to preserve this relevant
information across the filtering process.
A similar trend is also confirmed looking at the citation
data for the remaining two diseases reported in Figures 3
and 4.
In order to perform a more solid statistical validation
through the use of bibliometric data, we executed a set of
queries on ProteinQuest to understand if, given a disease,
the set of genes selected by our algorithm is highly cocited
with the disease while showing low citation count with the
other diseases. As an example, Algorithm 1 shows the query
executed to search for citation relevance of AML genes with
AML related publications. The query searches for papers
in which at least one of the selected genes is cocited with
the AML disease and not cocited either with BC or DLCL
diseases. The query produces, for each gene, the number of
papers in which the selected condition is respected.
Data obtained from the execution of these ProteinQuest
queries have been aggregated in Table 5 that reports, for each
group of filtered genes, the cumulative citation count for
each disease. The full set of data returned by the execution
of each query and used to construct Table 5 is available in
the disease citation heatmaps.xlsx file provided as additional
material of this paper. By construction, each query guarantees
that citations obtained on each column of the table are
disjoint.
We analyzed data reported in Table 5 using SAS software
(version 9.1.3; SAS Institute, Cary, NC, USA). In order to find
relationship between genes groups and diseases, frequencies
of citations have been analyzed. For each group of genes,
pairwise differences among diseases have been performed
using the FREQ procedure. Furthermore, Bonferroni adjust-
ment of the obtained 푃 values has been carried out with the
MULTTEST procedure.
The chi-square test reveals that citations frequencies
among diseases (AML, DLCL, and BC) significantly differ
by groups of selected genes (휒2(4) = 64, 897.4; 푃 < 0.0001).
Considering the first group of selected genes, the frequency
of citations referred to AML (49.79%) significantly differs
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Table 5: Citations of groups of filtered genes according to the disease.
Group of genes Disease Total
AML DLCL BC
Number 1 AML filtered genes 23,248 5,741 17,769 46,758
(49.72), [63.68] (12.28), [28.56] (38.00), [17.56]
Number 2 DLCL filtered genes 2,470 10,347 6,180 18,997
(13.00), [6.77] (54.47), [51.47] (32.53), [6.11]
Number 3 BC filtered genes 10,787 4,015 77,223 92,025
(11.72), [29.55] (4.36), [19.97] (83.92), [76.33]
Total 36,505 20,103 101,172
( ): percentage in rows; [ ]: percentage in columns.
SELECT
(G1 OR G2 OR . . . OR Gn) ∀ Gene ∈ {AML filtered genes}
AND “Leukemia, Myeloid, Acute”
AND NOT “Breast Neoplasm” OR . . . “Lymphoma, Large B-Cell, Diffuse”
Algorithm 1: ProteinQuest query example to obtain citation data for the AML dataset.
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Figure 2: AML preliminary bibliometric validation.
from both DLCL (휒2 = 13, 662; 푃 < 0.0001) and BC
(휒2 = 743.5; 푃 ≤ 0.0001) citations (12.28% and 38%, resp.).
Similarly, the proportion among citations in the second group
of selected genes highlights significant differences between
DLCL citations frequency (54.47%) and AML citations (13%;휒2 = 6, 496.5; 푃 < 0.0001) and between DLCL and BC
citations (32.53%; 휒2 = 1, 112.1; 푃 < 0.0001). Finally, greater
frequency of citations has been observed in the third group of
genes when comparing BC (83.92%) over AML (11.72%; 휒2 =3, 206.2; 푃 < 0.0001) and over DLCL (4.36%; 휒2 = 233, 024;푃 < 0.0001).The obtained results on frequencies of citations
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Figure 3: BC preliminary bibliometric validation.
support the ability of the algorithm in selecting appropriate
genes group according to the selected disease.
4. Conclusions
In this paper we proposed a multi-weighted network topol-
ogy, and a related algorithm for its analysis, that is able to
filter complex coexpression networks obtained from gene
expression data in order to reduce the network size and
to retain only those genes and those interactions that are
potentially related to a selected disease.
8 BioMed Research International
1
10
100
1000
10000
100000
1 10 100
DLCL ordered filtered genes rank (log)
BC gene citation ranking
AML gene citation ranking
DLCL gene citation ranking
Ci
ta
tio
n 
ra
nk
in
g (
lo
g)
−
ra
nk
=
1
→
to
p 
ra
nk
Figure 4: DLCL preliminary bibliometric validation.
The algorithm has been tested on three public datasets
for well-known studied diseases proving its high efficiency in
reducing the complexity of the network. Moreover, to show
that the filtering process is able to keep nodes, which are
relevant for a particular disease, a validation campaign that
resorts to bibliometric data mined through the ProteinQuest
tool is presented.
The proposed approach represents a valuable starting
point to reduce the complexity of complex biological net-
works in order to perform further analyses aiming at iden-
tifying interesting network motifs.
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